Has Cheguevara Afaneh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,406,594 in general payments to Cheguevara Afaneh, MD across 1,767 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cheguevara Afaneh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cheguevara Afaneh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cheguevara Afaneh, MD

Surgery · New York, NYNPI 1205089463

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (55.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 78.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $319,853 and has fallen 73.2% since, to $85,725 in 2025. Among surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,406,594in general payments, 2019–2025

Across 1,767 payments — averaging $796.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$1.1M
W. L. Gore & Associates, Inc.$290K
Johnson & Johnson$3K
Medical Device Business Services, Inc.$2K
Davol Inc.$2K
Asensus Surgical, Inc.$600
plus $2K from 14 others

$16,000in research payments, 2019–2025

Across 1 payment — averaging $16,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Intuitive Surgical Operations, Inc.$16K

What the payments were for

Consulting fees$62,0284%
Speaking & faculty fees$346,00525%
Travel & lodging$177,27813%
Food & beverage$34,4942%
Education$786,79156%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	1,389	$1,107,271
W. L. Gore & Associates, Inc.	338	$290,355
Johnson & Johnson(2 entities)	4	$3,494
Medical Device Business Services, Inc.	1	$1,513
Davol Inc.	8	$1,511
Asensus Surgical, Inc.	1	$600
BD	2	$543
Laborie Medical Technologies Corp.	2	$525
Boston Scientific	4	$344
Celltrion USA Inc.	2	$93
AbbVie	4	$85
Tactile Systems Technology Inc	2	$48
Lilly USA, LLC	2	$43
Takeda Pharmaceuticals U.S.A., Inc.	2	$39
Integra Lifesciences Corporation	1	$32
Conmed Corporation	1	$24
Solventum Corporation	1	$23
AstraZeneca	1	$21
Shire North American Group Inc	1	$16
Teleflex LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Da Vinci Surgical System$1,048,133
SYNECOR Biomaterial$157,639
GORE SYNECOR Biomaterial$83,486
GORE ENFORM Preperitoneal Biomaterial$68,441
GORE BIO-A Tissue Reinforcement$51,494
DA VINCI SP$49,600
GORE DUALMESH Biomaterial$25,383
GORE ENFORM Biomaterial$9,686
Product in Development$9,310
BIO-A Tissue Reinforcement$6,760
SEAMGUARD Staple Line Reinforcement$3,675
Senhance$1,800
PROGEL$294
SPYGLASS$264
Phasix Mesh$159
GORE SYNECOR Preperitoneal Biomaterial$150
GORE VIABIL Biliary Endoprosthesis$137
Bard 3DMax Mesh$135

How this compares

$1,406,594 in reported general payments places this provider in the 95th percentile of 1,596 surgery providers in New York.

See all surgery providers in New York →

Medicare billing

Part B allowed, 2024

$212,176

Medicare patients

318

Services billed

563

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	11	$34

Paid to pharmacies, not to this prescriber.

Other surgery in New York

Flavio Malcher Martins de OliveiraNew York$695K
Yuri NovitskyNew York$548K
Rasa ZarnegarNew York$478K
Tanuja DamaniNew York$459K
Rache SimmonsNew York$371K
Marina KurianNew York$328K
Megan JenkinsNew York$290K
Brian JacobNew York$225K
Robin BlackstoneNew York$174K
Mitchell RoslinNew York$156K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →